Concepedia

Laura Yunes‐Medina

LY

Statistics

Publications

4

Citations

399

H-Index

4

Active since

2019

Affiliations

Eli Lilly (United States)(Current)

Laura Yunes‐Medina is an author at Eli Lilly (United States) specializing in clinical pharmacology, pharmacology, and headache disorders.

Publications per year

2019–2021

4

Publications

4

Safety and efficacy of galcanezumab in patients for whom previous migraine preventive medication from two to four categories had failed (CONQUER): a multicentre, randomised, double-blind, placebo-controlled, phase 3b trial

Wim M. Mulleners, Byung‐Kun Kim, Miguel J. A. Láinez et al. · The Lancet Neurology · 2020 · 283 citations

, , +10

Safety and tolerability of monthly galcanezumab injections in patients with migraine: integrated results from migraine clinical studies

Mark E. Bangs, David Kudrow, Shufang Wang et al. · BMC Neurology · 2020 · 53 citations · Full text

, , +17

Onset of Efficacy Following Oral Treatment With Lasmiditan for the Acute Treatment of Migraine: Integrated Results From 2 Randomized Double‐Blind Placebo‐Controlled Phase 3 Clinical Studies

Raghavendra Vasudeva, Leah Jin, Louise Lombard et al. · Headache The Journal of Head and Face Pain · 2019 · 35 citations · Full text

, , +16

Early onset of effect following galcanezumab treatment in patients with previous preventive medication failures

Todd J. Schwedt, Dulanji Kuruppu, Katherine Standley et al. · The Journal of Headache and Pain · 2021 · 28 citations · Full text

, , +13

1–4 of 4